Position in VCYT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$18,664,406
-$8,022,530 QoQ
Shares Held
579,460
-8.6% QoQ
Ownership
0.726%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
6 quarters on record
Voting authority
Sole 84%
Shared 0%
None 16%
Common Shares in VCYT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026FRED ALGER MANAGEMENT, LLC holds $495,820,563 across 13 Diagnostics & Research names. VCYT ranks #4 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
|
1,756,472 | $351,276,835 | |
| 2 | GH |
Guardant Health, Inc.
|
622,259 | $57,478,063 | |
| 3 | RDNT |
RadNet, Inc.
|
341,938 | $19,110,914 | |
| 4 | VCYT |
Veracyte, Inc.
This page
|
579,460 | $18,664,406 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
24,268 | $13,635,946 | |
| 6 | WGS |
GeneDx Holdings Corp.
|
202,771 | $13,021,953 | |
| 7 | ADPT |
Adaptive Biotechnologies Corp
|
2,063,146 | $7,159,116 | |
| 8 | NEO |
Neogenomics Inc
|
651,649 | $4,835,235 |
All Filings in VCYT
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $18,664,406 | 579,460 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $26,686,936 | 633,894 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $26,347,552 | 767,479 | Shares | Sole | 2025-11-14 | |
| 2024-12-31 | $1,342,123 | 33,892 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $325,796 | 9,571 | Shares | Sole | 2024-11-14 | |
| 2022-06-30 | $257,565 | 12,943 | Shares | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||